ReP USP - Resultado da busca

Artigo de periodico
Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2021)
Damiano, Rodolfo Furlan ; Guedes, Bruno Fukelmann ; Rocca, Cristiana Castanho de; Serafim, Antonio de Pádua ; Castro, Luiz Henrique Martins; Munhoz, Carolina Demarchi ; Nitrini, Ricardo ; Busatto Filho, Geraldo ; Miguel Filho, Eurípedes Constantino ; Lucchetti, Giancarlo ; Forlenza, Orestes Vicente
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidades: IP, FM, ICB
Subjects: FARMACOLOGIA, DOENÇA DE ALZHEIMER, COVID-19, DEMÊNCIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMIANO, Rodolfo Furlan et al. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00406-021-01286-4. Acesso em: 07 nov. 2024.
APA
Damiano, R. F., Guedes, B. F., Rocca, C. C. de, Serafim, A. de P., Castro, L. H. M., Munhoz, C. D., et al. (2021). Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. European Archives of Psychiatry and Clinical Neuroscience, 1-16. doi:10.1007/s00406-021-01286-4
NLM
Damiano RF, Guedes BF, Rocca CC de, Serafim A de P, Castro LHM, Munhoz CD, Nitrini R, Busatto Filho G, Miguel Filho EC, Lucchetti G, Forlenza OV. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-021-01286-4
Vancouver
Damiano RF, Guedes BF, Rocca CC de, Serafim A de P, Castro LHM, Munhoz CD, Nitrini R, Busatto Filho G, Miguel Filho EC, Lucchetti G, Forlenza OV. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2021 ; 1-16.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-021-01286-4
Artigo de periodico
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study (2020)
Costa, Alana C.; Joaquim, Helena P. G.; Forlenza, Orestes Vicente ; Gattaz, Wagner Farid ; Talib, Leda L
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: METABOLÔMICA, TRANSTORNOS COGNITIVOS, BIOMARCADORES, DOENÇA DE ALZHEIMER, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C. et al. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, v. 270, n. 4, p. 483-488, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-01034-9. Acesso em: 07 nov. 2024.
APA
Costa, A. C., Joaquim, H. P. G., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2020). Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study. European archives of psychiatry and clinical neuroscience, 270( 4), 483-488. doi:10.1007/s00406-019-01034-9
NLM
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-019-01034-9
Vancouver
Costa AC, Joaquim HPG, Forlenza OV, Gattaz WF, Talib LL. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study [Internet]. European archives of psychiatry and clinical neuroscience. 2020 ; 270( 4): 483-488.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-019-01034-9
Artigo de periodico
Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients (2019)
Bram, Jessyka Maria de Franca; Talib, Leda Leme; Joaquim, Helena Passarelli Giroud; Sarno, Tamires Alves; Gattaz, Wagner Farid ; Forlenza, Orestes Vicente
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, BIOMARCADORES, LEUCÓCITOS, PROTEÍNAS DA MEMBRANA, PLAQUETAS SANGUÍNEAS, ENZIMAS PROTEOLÍTICAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAM, Jessyka Maria de Franca et al. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 269, n. 8, p. 963-972, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00406-018-0905-3. Acesso em: 07 nov. 2024.
APA
Bram, J. M. de F., Talib, L. L., Joaquim, H. P. G., Sarno, T. A., Gattaz, W. F., & Forlenza, O. V. (2019). Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 269( 8), 963-972. doi:10.1007/s00406-018-0905-3
NLM
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-018-0905-3
Vancouver
Bram JM de F, Talib LL, Joaquim HPG, Sarno TA, Gattaz WF, Forlenza OV. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2019 ; 269( 8): 963-972.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-018-0905-3
Artigo de periodico
Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease (2018)
Freitas, Maria Isabel D'Avila; Porto, Claudia S.; Oliveira, Maira O.; Brucki, Sonia M. D.; Mansur, Letícia Lessa; Nitrini, Ricardo; Radanovic, Marcia
Source: Acta neurologica belgica. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, TESTES NEUROPSICOLÓGICOS, LINGUÍSTICA COGNITIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Maria Isabel D'Avila et al. Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease. Acta neurologica belgica, v. 118, n. 3, p. 465-473, 2018Tradução . . Disponível em: https://doi.org/10.1007/s13760-018-0977-x. Acesso em: 07 nov. 2024.
APA
Freitas, M. I. D. 'A., Porto, C. S., Oliveira, M. O., Brucki, S. M. D., Mansur, L. L., Nitrini, R., & Radanovic, M. (2018). Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease. Acta neurologica belgica, 118( 3), 465-473. doi:10.1007/s13760-018-0977-x
NLM
Freitas MID'A, Porto CS, Oliveira MO, Brucki SMD, Mansur LL, Nitrini R, Radanovic M. Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease [Internet]. Acta neurologica belgica. 2018 ; 118( 3): 465-473.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s13760-018-0977-x
Vancouver
Freitas MID'A, Porto CS, Oliveira MO, Brucki SMD, Mansur LL, Nitrini R, Radanovic M. Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease [Internet]. Acta neurologica belgica. 2018 ; 118( 3): 465-473.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s13760-018-0977-x
Artigo de periodico
Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients (2018)
Costa, Alana C.; Joaquim, Helena P. G.; Nunes, Valeria S.; Kerr, Daniel S.; Ferreira, Guilherme S.; Forlenza, Orestes Vicente; Gattaz, Wagner Farid; Talib, Leda Leme
Source: European archives of psychiatry and clinical neuroscience. Unidade: FM
Subjects: COLESTEROL, DOENÇA DE ALZHEIMER, METABOLISMO, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Alana C. et al. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 268, n. 5, p. 501-507, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00406-017-0838-2. Acesso em: 07 nov. 2024.
APA
Costa, A. C., Joaquim, H. P. G., Nunes, V. S., Kerr, D. S., Ferreira, G. S., Forlenza, O. V., et al. (2018). Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 268( 5), 501-507. doi:10.1007/s00406-017-0838-2
NLM
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-017-0838-2
Vancouver
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-017-0838-2
Artigo de periodico
Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice (2017)
Schaeffer, Evelin L.; Catanozi, Sergio; West, Mark J.; Gattaz, Wagner F.
Source: Annals of anatomy. Unidade: FM
Subjects: LÍTIO, DOENÇA DE ALZHEIMER, NEURÔNIOS, EVENTO ADVERSO A MEDICAMENTO, DOENÇAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. et al. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. Annals of anatomy, v. 209, p. 51-60, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.aanat.2016.10.002. Acesso em: 07 nov. 2024.
APA
Schaeffer, E. L., Catanozi, S., West, M. J., & Gattaz, W. F. (2017). Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. Annals of anatomy, 209, 51-60. doi:10.1016/j.aanat.2016.10.002
NLM
Schaeffer EL, Catanozi S, West MJ, Gattaz WF. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice [Internet]. Annals of anatomy. 2017 ; 209 51-60.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.aanat.2016.10.002
Vancouver
Schaeffer EL, Catanozi S, West MJ, Gattaz WF. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice [Internet]. Annals of anatomy. 2017 ; 209 51-60.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.aanat.2016.10.002
Artigo de periodico
Recalling feature bindings differentiates Alzheimer’s disease from frontotemporal dementia (2017)
Cecchini, Mario Amore ; Yassuda, Monica Sanches ; Bahia, Valéria Santoro; Souza, Leonardo Cruz de ; Guimarães, Henrique Cerqueira ; Caramelli, Paulo ; Goulart, Maria Teresa Carthery; Patrocínio, Flávia Andréa Prado; Foss, Maria Paula ; Tumas, Vitor ; Silva, Thaís Bento Lima da ; Brucki, Sonia Maria Dozzi ; Nitrini, Ricardo ; Della Sala, Sergio ; Parra, Mario Alfredo
Source: Journal of Neurology. Unidades: EACH, FMRP, FM
Subjects: DOENÇA DE ALZHEIMER, DEMÊNCIA, MEMÓRIA DE CURTO PRAZO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CECCHINI, Mario Amore et al. Recalling feature bindings differentiates Alzheimer’s disease from frontotemporal dementia. Journal of Neurology, v. 264, n. 10, p. 2162-2169, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00415-017-8614-9. Acesso em: 07 nov. 2024.
APA
Cecchini, M. A., Yassuda, M. S., Bahia, V. S., Souza, L. C. de , Guimarães, H. C. , Caramelli, P., et al. (2017). Recalling feature bindings differentiates Alzheimer’s disease from frontotemporal dementia. Journal of Neurology, 264( 10), 2162-2169. doi:10.1007/s00415-017-8614-9
NLM
Cecchini MA, Yassuda MS, Bahia VS, Souza L C de , Guimarães H C , Caramelli P, Goulart MTC, Patrocínio FAP, Foss M P , Tumas V , Silva TBL da, Brucki SMD, Nitrini R, Della Sala S , Parra M A. Recalling feature bindings differentiates Alzheimer’s disease from frontotemporal dementia [Internet]. Journal of Neurology. 2017 ; 264( 10): 2162-2169.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00415-017-8614-9
Vancouver
Cecchini MA, Yassuda MS, Bahia VS, Souza L C de , Guimarães H C , Caramelli P, Goulart MTC, Patrocínio FAP, Foss M P , Tumas V , Silva TBL da, Brucki SMD, Nitrini R, Della Sala S , Parra M A. Recalling feature bindings differentiates Alzheimer’s disease from frontotemporal dementia [Internet]. Journal of Neurology. 2017 ; 264( 10): 2162-2169.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00415-017-8614-9
Artigo de periodico
Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop (2016)
Schrötter, Andreas; Park, Young Mok; Marcus, Katrin; Martins-de-Souza, Daniel; Nilsson, Peter; El Magraoui, Fouzi; Meyer, Helmut E.; Grinberg, Lea T.
Source: Proteomics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, DOENÇAS NEURODEGENERATIVAS, ESCLEROSE AMIOTRÓFICA LATERAL, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHRÖTTER, Andreas et al. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop. Proteomics, v. 16, n. 7, p. 1047-1050, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdf. Acesso em: 07 nov. 2024.
APA
Schrötter, A., Park, Y. M., Marcus, K., Martins-de-Souza, D., Nilsson, P., El Magraoui, F., et al. (2016). Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop. Proteomics, 16( 7), 1047-1050. doi:10.1002/pmic.201600047
NLM
Schrötter A, Park YM, Marcus K, Martins-de-Souza D, Nilsson P, El Magraoui F, Meyer HE, Grinberg LT. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop [Internet]. Proteomics. 2016 ; 16( 7): 1047-1050.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdf
Vancouver
Schrötter A, Park YM, Marcus K, Martins-de-Souza D, Nilsson P, El Magraoui F, Meyer HE, Grinberg LT. Key players in neurodegenerative disorders in focus—New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis—24th HUPO BPP Workshop [Internet]. Proteomics. 2016 ; 16( 7): 1047-1050.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201600047/epdf
Artigo de periodico
Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015)
Talib, L. L.; Hototian, S. R.; Joaquim, H. P. G.; Forlenza, O. V.; Gattaz, W. F.
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, FÁRMACOS (SISTEMA NERVOSO CENTRAL), PROTEÍNAS QUINASES, FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TALIB, L. L. et al. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 8, p. 701-706, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00406-015-0600-6. Acesso em: 07 nov. 2024.
APA
Talib, L. L., Hototian, S. R., Joaquim, H. P. G., Forlenza, O. V., & Gattaz, W. F. (2015). Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience, 265( 8), 701-706. doi:10.1007/s00406-015-0600-6
NLM
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Vancouver
Talib LL, Hototian SR, Joaquim HPG, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 8): 701-706.[citado 2024 nov. 07 ] Available from: http://link.springer.com/article/10.1007/s00406-015-0600-6
Artigo de periodico
Selenium status in elderly: Relation to cognitive decline (2014)
Cardoso, Bárbara Rita; Bandeira, Verônica Silva; Jacob-Filho, Wilson; Cozzolino, Silvia Maria Franciscato
Source: Journal of Trace Elements in Medicine and Biology. Unidades: FM, FCF
Subjects: SELÊNIO, IDOSOS, DOENÇA DE ALZHEIMER, TRANSTORNOS COGNITIVOS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Bárbara Rita et al. Selenium status in elderly: Relation to cognitive decline. Journal of Trace Elements in Medicine and Biology, v. 28, n. 4, p. 422-426, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jtemb.2014.08.009. Acesso em: 07 nov. 2024.
APA
Cardoso, B. R., Bandeira, V. S., Jacob-Filho, W., & Cozzolino, S. M. F. (2014). Selenium status in elderly: Relation to cognitive decline. Journal of Trace Elements in Medicine and Biology, 28( 4), 422-426. doi:10.1016/j.jtemb.2014.08.009
NLM
Cardoso BR, Bandeira VS, Jacob-Filho W, Cozzolino SMF. Selenium status in elderly: Relation to cognitive decline [Internet]. Journal of Trace Elements in Medicine and Biology. 2014 ; 28( 4): 422-426.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jtemb.2014.08.009
Vancouver
Cardoso BR, Bandeira VS, Jacob-Filho W, Cozzolino SMF. Selenium status in elderly: Relation to cognitive decline [Internet]. Journal of Trace Elements in Medicine and Biology. 2014 ; 28( 4): 422-426.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jtemb.2014.08.009
Artigo de periodico
Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop (2013)
Gröttrup, Bernd; Esselmann, Hermann; May, Caroline; Schrötter, Andreas; Woitalla, Dirk; Heinsen, Helmut; Marcus, Katrin; Wiltfang, Jens; Meyer, Helmut E.; Grinberg, Lea T.; Park, Young Mok
Source: Proteomics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, DOENÇAS NEURODEGENERATIVAS, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRÖTTRUP, Bernd et al. Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop. Proteomics, v. 13, n. 2, p. 210-216, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370025/pdf. Acesso em: 07 nov. 2024.
APA
Gröttrup, B., Esselmann, H., May, C., Schrötter, A., Woitalla, D., Heinsen, H., et al. (2013). Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop. Proteomics, 13( 2), 210-216. doi:10.1002/pmic.201370025
NLM
Gröttrup B, Esselmann H, May C, Schrötter A, Woitalla D, Heinsen H, Marcus K, Wiltfang J, Meyer HE, Grinberg LT, Park YM. Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop [Internet]. Proteomics. 2013 ; 13( 2): 210-216.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370025/pdf
Vancouver
Gröttrup B, Esselmann H, May C, Schrötter A, Woitalla D, Heinsen H, Marcus K, Wiltfang J, Meyer HE, Grinberg LT, Park YM. Challenges in Modern Biomarker Discovery – 17th HUPO BPP Workshop [Internet]. Proteomics. 2013 ; 13( 2): 210-216.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370025/pdf
Artigo de periodico
Early Diagnosis of Neurodegenerative Diseases – The Long Awaited Holy Grail and Bottleneck of Modern Brain Research – 19th HUPO BPP Workshop (2013)
Schrötter, Andreas; Magraoui, Fouzi El; Gröttrup, Bernd; Wiltfang, Jens; Heinsen, Helmut; Marcus, Katrin; Meyer, Helmut E.; Grinberg, Lea T.; Park, Young Mok
Source: Proteomics. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, DOENÇAS NEURODEGENERATIVAS (DIAGNÓSTICO), DOENÇA DE PARKINSON (DIAGNÓSTICO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHRÖTTER, Andreas et al. Early Diagnosis of Neurodegenerative Diseases – The Long Awaited Holy Grail and Bottleneck of Modern Brain Research – 19th HUPO BPP Workshop. Proteomics, v. 13, n. 2, p. 2938-2941, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370164/pdf. Acesso em: 07 nov. 2024.
APA
Schrötter, A., Magraoui, F. E., Gröttrup, B., Wiltfang, J., Heinsen, H., Marcus, K., et al. (2013). Early Diagnosis of Neurodegenerative Diseases – The Long Awaited Holy Grail and Bottleneck of Modern Brain Research – 19th HUPO BPP Workshop. Proteomics, 13( 2), 2938-2941. doi:10.1002/pmic.201370164
NLM
Schrötter A, Magraoui FE, Gröttrup B, Wiltfang J, Heinsen H, Marcus K, Meyer HE, Grinberg LT, Park YM. Early Diagnosis of Neurodegenerative Diseases – The Long Awaited Holy Grail and Bottleneck of Modern Brain Research – 19th HUPO BPP Workshop [Internet]. Proteomics. 2013 ; 13( 2): 2938-2941.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370164/pdf
Vancouver
Schrötter A, Magraoui FE, Gröttrup B, Wiltfang J, Heinsen H, Marcus K, Meyer HE, Grinberg LT, Park YM. Early Diagnosis of Neurodegenerative Diseases – The Long Awaited Holy Grail and Bottleneck of Modern Brain Research – 19th HUPO BPP Workshop [Internet]. Proteomics. 2013 ; 13( 2): 2938-2941.[citado 2024 nov. 07 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201370164/pdf
Artigo de periodico
Disequilibrium coefficient: a bayesian perspective (2011)
Brentani, Helena; Nakano, Eduardo Y.; Martins, Camila B.; Izbicki, Rafael; Pereira, Carlos Alberto de Bragança
Source: Statistical Applications in Genetics and Molecular Biology. Unidades: FM, IME
Subjects: TESTES DE HIPÓTESES, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRENTANI, Helena et al. Disequilibrium coefficient: a bayesian perspective. Statistical Applications in Genetics and Molecular Biology, v. 10, n. 1, p. 1-24, 2011Tradução . . Disponível em: https://doi.org/10.2202/1544-6115.1636. Acesso em: 07 nov. 2024.
APA
Brentani, H., Nakano, E. Y., Martins, C. B., Izbicki, R., & Pereira, C. A. de B. (2011). Disequilibrium coefficient: a bayesian perspective. Statistical Applications in Genetics and Molecular Biology, 10( 1), 1-24. doi:10.2202/1544-6115.1636
NLM
Brentani H, Nakano EY, Martins CB, Izbicki R, Pereira CA de B. Disequilibrium coefficient: a bayesian perspective [Internet]. Statistical Applications in Genetics and Molecular Biology. 2011 ; 10( 1): 1-24.[citado 2024 nov. 07 ] Available from: https://doi.org/10.2202/1544-6115.1636
Vancouver
Brentani H, Nakano EY, Martins CB, Izbicki R, Pereira CA de B. Disequilibrium coefficient: a bayesian perspective [Internet]. Statistical Applications in Genetics and Molecular Biology. 2011 ; 10( 1): 1-24.[citado 2024 nov. 07 ] Available from: https://doi.org/10.2202/1544-6115.1636
Artigo de periodico
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease (2009)
Schaeffer, Evelin L.; Forlenza, Orestes V.; Gattaz, Wagner F.
Source: Psychopharmacology. Unidade: FM
Subjects: COGNIÇÃO (TREINAMENTO), TRANSTORNOS COGNITIVOS (PREVENÇÃO E CONTROLE), DOENÇA DE ALZHEIMER, FOSFOLIPASES A (ATIVIDADE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. e FORLENZA, Orestes V. e GATTAZ, Wagner F. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology, v. 202, n. 1-3, p. 37-51, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00213-008-1351-0. Acesso em: 07 nov. 2024.
APA
Schaeffer, E. L., Forlenza, O. V., & Gattaz, W. F. (2009). Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology, 202( 1-3), 37-51. doi:10.1007/s00213-008-1351-0
NLM
Schaeffer EL, Forlenza OV, Gattaz WF. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease [Internet]. Psychopharmacology. 2009 ; 202( 1-3): 37-51.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-008-1351-0
Vancouver
Schaeffer EL, Forlenza OV, Gattaz WF. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease [Internet]. Psychopharmacology. 2009 ; 202( 1-3): 37-51.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-008-1351-0
Artigo de periodico
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease (2009)
Diniz, Breno Satler; Pinto Junior, Jony Arrais; Gonzaga, Maria Luiza Cavichioli; Guimarães, Fabiana Meira; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: European Archives of Psychiatry and Clinical Neurosciences. Unidade: FM
Subjects: METANÁLISE, DOENÇA DE ALZHEIMER, EVOLUÇÃO CLÍNICA, TRANSTORNOS COGNITIVOS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Breno Satler et al. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, v. 259, n. 4, p. 248-256, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00406-008-0864-1. Acesso em: 07 nov. 2024.
APA
Diniz, B. S., Pinto Junior, J. A., Gonzaga, M. L. C., Guimarães, F. M., Gattaz, W. F., & Forlenza, O. V. (2009). To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, 259( 4), 248-256. doi:10.1007/s00406-008-0864-1
NLM
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-008-0864-1
Vancouver
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00406-008-0864-1
Artigo de periodico
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme (2008)
Schaeffer, Evelin L.; Gattaz, Wagner F.
Source: Psychopharmacology. Unidade: FM
Subjects: MEMÓRIA, DOENÇA DE ALZHEIMER, FOSFOLIPASES A, RECEPTORES COLINÉRGICOS, ÁCIDO GLUTÂMICO, TRANSTORNOS COGNITIVOS, SISTEMA NERVOSO PARASSIMPÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. e GATTAZ, Wagner F. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology, v. 198, n. 1, p. 1-27, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00213-008-1092-0. Acesso em: 07 nov. 2024.
APA
Schaeffer, E. L., & Gattaz, W. F. (2008). Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology, 198( 1), 1-27. doi:10.1007/s00213-008-1092-0
NLM
Schaeffer EL, Gattaz WF. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme [Internet]. Psychopharmacology. 2008 ; 198( 1): 1-27.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-008-1092-0
Vancouver
Schaeffer EL, Gattaz WF. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme [Internet]. Psychopharmacology. 2008 ; 198( 1): 1-27.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-008-1092-0
Trabalho de evento-resumo periodico
The dorsal raphe nucleus shows phospho-tau cytoskeletal changes before the transentorhinal region in AD. A new (or earlier) beginning? (2008)
Grinberg, *L.T.; Rub, U; Ferretti-Rebustini, Renata Eloah de Lucena ; Nitrini, R.; Farfel, J. M.; Leite, R. E. P.; Polichiso, L.; Alho, A. T. L.; Oliveira, K. C.; Lima, M. C.; Moreira, E. G.; Santos, E. B.; Andrade, M. P.; Pasqualucci, C. A.; Jacob-Filho, W.; Saldiva, Paulo Hilário Nascimento ; Gierga, K.; Heisen, H.
Source: Acta neuropathologica. Conference titles: Annual Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN). Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, CÉLULAS-TRONCO (TRANSPLANTE), DOENÇAS NEURODEGENERATIVAS, PROTÉINAS (ANÁLISE), CONFERÊNCIA INTERNACIONAL, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRINBERG, *L.T. et al. The dorsal raphe nucleus shows phospho-tau cytoskeletal changes before the transentorhinal region in AD. A new (or earlier) beginning?. Acta neuropathologica. Berlin: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.springerlink.com/content/k56r7262651j2258/fulltext.pdf. Acesso em: 07 nov. 2024. , 2008
APA
Grinberg, *L. T., Rub, U., Ferretti-Rebustini, R. E. de L., Nitrini, R., Farfel, J. M., Leite, R. E. P., et al. (2008). The dorsal raphe nucleus shows phospho-tau cytoskeletal changes before the transentorhinal region in AD. A new (or earlier) beginning? Acta neuropathologica. Berlin: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.springerlink.com/content/k56r7262651j2258/fulltext.pdf
NLM
Grinberg *LT, Rub U, Ferretti-Rebustini RE de L, Nitrini R, Farfel JM, Leite REP, Polichiso L, Alho ATL, Oliveira KC, Lima MC, Moreira EG, Santos EB, Andrade MP, Pasqualucci CA, Jacob-Filho W, Saldiva PHN, Gierga K, Heisen H. The dorsal raphe nucleus shows phospho-tau cytoskeletal changes before the transentorhinal region in AD. A new (or earlier) beginning? [Internet]. Acta neuropathologica. 2008 ; 116( 3): 343.[citado 2024 nov. 07 ] Available from: http://www.springerlink.com/content/k56r7262651j2258/fulltext.pdf
Vancouver
Grinberg *LT, Rub U, Ferretti-Rebustini RE de L, Nitrini R, Farfel JM, Leite REP, Polichiso L, Alho ATL, Oliveira KC, Lima MC, Moreira EG, Santos EB, Andrade MP, Pasqualucci CA, Jacob-Filho W, Saldiva PHN, Gierga K, Heisen H. The dorsal raphe nucleus shows phospho-tau cytoskeletal changes before the transentorhinal region in AD. A new (or earlier) beginning? [Internet]. Acta neuropathologica. 2008 ; 116( 3): 343.[citado 2024 nov. 07 ] Available from: http://www.springerlink.com/content/k56r7262651j2258/fulltext.pdf
Artigo de periodico
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline (2007)
Zainaghi, Isis A; Forlenza, Orestes V; Gattaz, Wagner Farid
Source: Pshychopharmacology. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, TRANSTORNOS COGNITIVOS, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAINAGHI, Isis A e FORLENZA, Orestes V e GATTAZ, Wagner Farid. Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Pshychopharmacology, v. 192, n. 4, p. 547-553, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00213-007-0748-5. Acesso em: 07 nov. 2024.
APA
Zainaghi, I. A., Forlenza, O. V., & Gattaz, W. F. (2007). Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Pshychopharmacology, 192( 4), 547-553. doi:10.1007/s00213-007-0748-5
NLM
Zainaghi IA, Forlenza OV, Gattaz WF. Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline [Internet]. Pshychopharmacology. 2007 ; 192( 4): 547-553.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-007-0748-5
Vancouver
Zainaghi IA, Forlenza OV, Gattaz WF. Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline [Internet]. Pshychopharmacology. 2007 ; 192( 4): 547-553.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-007-0748-5
Artigo de periodico
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory (2005)
Schaeffer, Evelin L.; Gattaz, Wagner F.
Source: Psychopharmacology. Unidade: FM
Subjects: RATOS, TRANSTORNOS DA MEMÓRIA, DOENÇA DE ALZHEIMER, HIPOCAMPU DE ANIMAL, CÁLCIO, FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAEFFER, Evelin L. e GATTAZ, Wagner F. Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory. Psychopharmacology, v. 181, n. 2, p. 392-400, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00213-005-2256-9. Acesso em: 07 nov. 2024.
APA
Schaeffer, E. L., & Gattaz, W. F. (2005). Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory. Psychopharmacology, 181( 2), 392-400. doi:10.1007/s00213-005-2256-9
NLM
Schaeffer EL, Gattaz WF. Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory [Internet]. Psychopharmacology. 2005 ; 181( 2): 392-400.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-005-2256-9
Vancouver
Schaeffer EL, Gattaz WF. Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory [Internet]. Psychopharmacology. 2005 ; 181( 2): 392-400.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-005-2256-9
Artigo de periodico
Reduced phospholipid breakdown in Alzheimers brains: a 31P spectroscopy study (2005)
Forlenza, Orestes V.; Wacker, Priscilla; Nunes, Paula V.; Yacubian, Juliana; Castro, Claudio C.; Otaduy, Maria C. G.; Gattaz, Wagner F.
Source: Psychopharmacology. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, DEMÊNCIA (METABOLISMO), FOSFOLIPÍDEOS (REDUÇÃO;METABOLISMO), ESPECTROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes V. et al. Reduced phospholipid breakdown in Alzheimers brains: a 31P spectroscopy study. Psychopharmacology, v. 180, n. 2, p. 359-365, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00213-005-2168-8. Acesso em: 07 nov. 2024.
APA
Forlenza, O. V., Wacker, P., Nunes, P. V., Yacubian, J., Castro, C. C., Otaduy, M. C. G., & Gattaz, W. F. (2005). Reduced phospholipid breakdown in Alzheimers brains: a 31P spectroscopy study. Psychopharmacology, 180( 2), 359-365. doi:10.1007/s00213-005-2168-8
NLM
Forlenza OV, Wacker P, Nunes PV, Yacubian J, Castro CC, Otaduy MCG, Gattaz WF. Reduced phospholipid breakdown in Alzheimers brains: a 31P spectroscopy study [Internet]. Psychopharmacology. 2005 ; 180( 2): 359-365.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-005-2168-8
Vancouver
Forlenza OV, Wacker P, Nunes PV, Yacubian J, Castro CC, Otaduy MCG, Gattaz WF. Reduced phospholipid breakdown in Alzheimers brains: a 31P spectroscopy study [Internet]. Psychopharmacology. 2005 ; 180( 2): 359-365.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1007/s00213-005-2168-8

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation